Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Reduction of treatment-related toxicities have direct bearing on the decision when to initiate antiretroviral therapy. Clinicians may opt to delay antiretroviral therapy or avoid certain agents because of quality-of-life issues and the risk of treatment-related toxicity.

Updates By Carol A. Kemper